<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Prospective Grant of Exclusive License: Her2 Monoclonal Antibodies, Antibody Drug Conjugates, and Site Specific Antibody Conjugate Methods for the Treatment of Cancer</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Prospective Grant of Exclusive License: Her2 Monoclonal Antibodies, Antibody Drug Conjugates, and Site Specific Antibody Conjugate Methods for the Treatment of Cancer</h1>
    <p class="timestamp">Published: 2015-01-06 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>This is notice, in accordance with 35 U.S.C. 209 and 37 CFR part 404, that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to HUIYU Pharmaceuticals Co, Ltd located in Neijiang City, CHINA to practice the inventions embodied in U.S. Provisional Patent Application 61/833,732, filed June 11, 2013 entitled "Her2-Specific Monoclonal Antibodies and Conjugates Thereof" [HHS Ref. No.: E-351- 2013/0-US-01], and Internat...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, National Institutes of Health</p>
    <p><strong>Document Number:</strong> 2014-30878</p>
    <p><strong>Publication Date:</strong> 2015-01-06</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2015/01/06/2014-30878/prospective-grant-of-exclusive-license-her2-monoclonal-antibodies-antibody-drug-conjugates-and-site">https://www.federalregister.gov/documents/2015/01/06/2014-30878/prospective-grant-of-exclusive-license-her2-monoclonal-antibodies-antibody-drug-conjugates-and-site</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2014-30878</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
